BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25464900)

  • 1. AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.
    Deshpande AJ; Deshpande A; Sinha AU; Chen L; Chang J; Cihan A; Fazio M; Chen CW; Zhu N; Koche R; Dzhekieva L; Ibáñez G; Dias S; Banka D; Krivtsov A; Luo M; Roeder RG; Bradner JE; Bernt KM; Armstrong SA
    Cancer Cell; 2014 Dec; 26(6):896-908. PubMed ID: 25464900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Wang GG; Cai L; Pasillas MP; Kamps MP
    Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DOTting the path to doom: how acceleration of histone methylation leads to leukemia.
    Bach C; Slany RK
    Cancer Cell; 2014 Dec; 26(6):781-782. PubMed ID: 25490442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l.
    Deshpande AJ; Chen L; Fazio M; Sinha AU; Bernt KM; Banka D; Dias S; Chang J; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
    Blood; 2013 Mar; 121(13):2533-41. PubMed ID: 23361907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia.
    Wang WT; Chen TQ; Zeng ZC; Pan Q; Huang W; Han C; Fang K; Sun LY; Yang QQ; Wang D; Luo XQ; Sun YM; Chen YQ
    J Hematol Oncol; 2020 Jun; 13(1):78. PubMed ID: 32552847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.
    Bernt KM; Zhu N; Sinha AU; Vempati S; Faber J; Krivtsov AV; Feng Z; Punt N; Daigle A; Bullinger L; Pollock RM; Richon VM; Kung AL; Armstrong SA
    Cancer Cell; 2011 Jul; 20(1):66-78. PubMed ID: 21741597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.
    Chen L; Deshpande AJ; Banka D; Bernt KM; Dias S; Buske C; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
    Leukemia; 2013 Apr; 27(4):813-22. PubMed ID: 23138183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3K79 methylation profiles define murine and human MLL-AF4 leukemias.
    Krivtsov AV; Feng Z; Lemieux ME; Faber J; Vempati S; Sinha AU; Xia X; Jesneck J; Bracken AP; Silverman LB; Kutok JL; Kung AL; Armstrong SA
    Cancer Cell; 2008 Nov; 14(5):355-68. PubMed ID: 18977325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.
    Kuntimaddi A; Achille NJ; Thorpe J; Lokken AA; Singh R; Hemenway CS; Adli M; Zeleznik-Le NJ; Bushweller JH
    Cell Rep; 2015 May; 11(5):808-20. PubMed ID: 25921540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias.
    Lin YH; Kakadia PM; Chen Y; Li YQ; Deshpande AJ; Buske C; Zhang KL; Zhang Y; Xu GL; Bohlander SK
    Blood; 2009 Jul; 114(3):651-8. PubMed ID: 19443658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival.
    Zhang W; Zhao C; Zhao J; Zhu Y; Weng X; Chen Q; Sun H; Mi JQ; Li J; Zhu J; Chen Z; Pandolfi PP; Chen S; Yan X; Xu J
    Theranostics; 2018; 8(16):4359-4371. PubMed ID: 30214626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUP98-MLL fusion in human acute myeloblastic leukemia.
    Kaltenbach S; Soler G; Barin C; Gervais C; Bernard OA; Penard-Lacronique V; Romana SP
    Blood; 2010 Sep; 116(13):2332-5. PubMed ID: 20558618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
    Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
    Clin Epigenetics; 2019 Dec; 11(1):199. PubMed ID: 31888761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
    Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PZP Domain of AF10 Senses Unmodified H3K27 to Regulate DOT1L-Mediated Methylation of H3K79.
    Chen S; Yang Z; Wilkinson AW; Deshpande AJ; Sidoli S; Krajewski K; Strahl BD; Garcia BA; Armstrong SA; Patel DJ; Gozani O
    Mol Cell; 2015 Oct; 60(2):319-27. PubMed ID: 26439302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
    Pineault N; Abramovich C; Ohta H; Humphries RK
    Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.
    Conway AE; Scotland PB; Lavau CP; Wechsler DS
    Blood; 2013 Jun; 121(23):4758-68. PubMed ID: 23487024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Wnt signaling target gene expression by the histone methyltransferase DOT1L.
    Gibbons GS; Owens SR; Fearon ER; Nikolovska-Coleska Z
    ACS Chem Biol; 2015 Jan; 10(1):109-14. PubMed ID: 25361163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characteristics of coiled-coil regions in AF10-DOT1L and AF10-inhibitory peptide complex.
    Zhou Z; Kang S; Huang Z; Zhou Z; Chen S
    J Leukoc Biol; 2021 Dec; 110(6):1091-1099. PubMed ID: 33993518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.